Home
Obi Profile
Fees
Services
News
Publications
Contact
You are here:
Title Details
Search
Login
METHOD OF PROVIDING PIRFENIDONE THERAPY TO A PATIENT
No-Receipt date
2011-01866 - 07/06/2011
No-Filing date
20110401330 - 07/06/2011
No-Granting date
3075178 - 08/06/2011
No-EPO application date
07865831.7 - 18/12/2007
No-EPO granting date
2124945 - 20/04/2011
Gazette No-Publication date of application
-
Gazette No-Publication date of granted patent
6/2011 - 14/07/2011
Expiration date
19/12/2027
Kind of title
Validation of European Patent
Legal status
VALID
Priorities
US870593 P18/12/2006/US
Active Substance of Supplementary Certificates
-
IPC Classification
Ipc Class
A61K 31/4412
Related Documents
Related Titles
Owners
Code
Firstname
Surname
Address
Town
ZIP
Country
1216907
INTERMUNE, INC.
1DNA WAY, SOUTH SAN FRANCISCO,
CA 94080-4990, U.S.A.
UNITED STATES OF AMERICA (USA)
Inventors
Code
Firstname
Surname
871297
BRADFORD, WILLIAMSON ZIEGLER
Representatives
Code
Firstname
Surname
Address
Town
Zip
25
MARIA
ATHANASIADOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
Contact
Code
Firstname
Surname
Address
Town
Zip
Country
848
EFANGELIA
GIAZITZOGLOU - THOMAIDOU
KOUMPARI 2
ATHINA (ATTIKIS)
10674
GREECE
Owners History
Date
Description
Comments
Data before modification
Data after modification
19/06/2020
Αλλαγή Έδρας (7e805)
Α.Π.899-ΑΡ.ΥΠ.2054454/2-20, ΔΝΥ312, ΚΩΔ.ΠΛΗΡ.3458
368882 Intermune, Inc. 3280 Bayshore Boulevard ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ Brisbane, CA 94005-1021
1216907 Intermune, Inc. 1DNA Way, South San Francisco, ΗΝΩΜΕΝΕΣ ΠΟΛΙΤΕΙΕΣ ΤΗΣ ΑΜΕΡΙΚΗΣ CA 94080-4990, U.S.A.
Title Instruments
Date
Operation
Descreption
5/17/2023 12:00:00 AM
Διάφορες Μεταβολές (70004)
ΑΡ.ΠΡΩΤ. 4430/10-02-2023 (ΛΙΣΤΑ) (ΑΡ.ΥΠΟΘ. 4654017/10-02-2023) ΔΝΥ. 440 ΚΩΔ.ΠΛΗΡ. 3464 ΑΡΣΗ & ΑΝΤΙΚΑΤΑΣΤΑΣΗ ΑΝΤΙΚΛΗΤΟΥ
Payments history
17 renewals have been done
© OBI all rights reserved
designed & developed by PROFILE S.A.
Certified QMS :
EN ISO 9001:2015
and
ΕΝ ISO 14001:2015
The project "Internet technological information diffusion from industrial property titles" is co-financed 70% by the European Regional Development Found and 30% by the Hellenic public sector (Operational programme "Competitiveness", Measure 4.4).